KETALAR Side Effects

7027397-0 | Cystitis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 19 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis. Ketalar dosage: .

7027396-9 | Cystitis
Patient was taking Ketalar (View Usage). Patient had the following side effects: cystitis on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 36 years of age, . Ketalar dosage: .

7027395-7 | Cystitis
Adverse event was reported on Sep 21, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: 12 G, Daily) . Location: UNITED KINGDOM , 27 years of age, After Ketalar was administered, patient had the following side effects: cystitis.

7027394-5 | Cystitis, Hydronephrosis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 27 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis, hydronephrosis. Ketalar dosage: .


7027393-3 | Cystitis, Hydronephrosis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 30 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: cystitis, hydronephrosis. Ketalar dosage: 4 G Daily.

7027389-1 | Cystitis
Patient was taking Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: cystitis on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 24 years of age, . Ketalar dosage: .

7027388-X | Cystitis
Adverse event was reported on Sep 21, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 27 years of age, Patient experienced the following unwanted or unexpected effects: cystitis.

7026815-1 | Bladder Hypertrophy, Cystitis, Reduced Bladder Capacity
on Sep 21, 2010 Male patient from UNITED KINGDOM , 19 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: bladder hypertrophy, cystitis, reduced bladder capacity. Ketalar dosage: .

7026814-X | Cystitis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 23 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: cystitis. Ketalar dosage: .

7026813-8 | Bladder Hypertrophy, Cystitis, Reduced Bladder Capacity
Patient was taking Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: bladder hypertrophy, cystitis, reduced bladder capacity on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 15 years of age, . Ketalar dosage: .

7026804-7 | Bladder Hypertrophy, Cystitis, Reduced Bladder Capacity
Adverse event was reported on Sep 21, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 24 years of age, Patient had the following side effects: bladder hypertrophy, cystitis, reduced bladder capacity.

7026743-1 | Cystitis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 31 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: cystitis. Ketalar dosage: .

7026733-9 | Cystitis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 21 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis. Ketalar dosage: .

7026722-4 | Cystitis
Patient was taking Ketalar (View Usage). Patient had the following side effects: cystitis on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 27 years of age, . Ketalar dosage: .

7026721-2 | Bladder Hypertrophy, Cystitis, Reduced Bladder Capacity
Adverse event was reported on Sep 21, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 32 years of age, After Ketalar was administered, patient had the following side effects: bladder hypertrophy, cystitis, reduced bladder capacity.

7026718-2 | Cystitis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 23 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis. Ketalar dosage: .

7026717-0 | Bladder Hypertrophy, Cystitis Bacterial
on Sep 21, 2010 Female patient from UNITED KINGDOM , 20 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: bladder hypertrophy, cystitis bacterial. Ketalar dosage: .

7026716-9 | Cystitis
Patient was taking Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: cystitis on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 23 years of age, . Ketalar dosage: .

7026710-8 | Bladder Disorder, Bladder Hypertrophy, Cystitis
Adverse event was reported on Sep 21, 2010 by a Female patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 16 years of age, Patient experienced the following unwanted or unexpected effects: bladder disorder, bladder hypertrophy, cystitis.

7026709-1 | Bladder Hypertrophy, Cystitis
on Sep 21, 2010 Male patient from UNITED KINGDOM , 21 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: bladder hypertrophy, cystitis. Ketalar dosage: .

7025032-9 | Bladder Hypertrophy, Cystitis, Reduced Bladder Capacity
on Sep 21, 2010 Female patient from UNITED KINGDOM , 22 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: bladder hypertrophy, cystitis, reduced bladder capacity. Ketalar dosage: .

7025026-3 | Bladder Hypertrophy, Cystitis, Reduced Bladder Capacity
Patient was taking Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: bladder hypertrophy, cystitis, reduced bladder capacity on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 19 years of age, . Ketalar dosage: .

7025024-X | Cystitis
Adverse event was reported on Sep 21, 2010 by a Female patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 18 years of age, Patient had the following side effects: cystitis.

6992549-2 | Dilatation Intrahepatic Duct Acquired, Hepatotoxicity, Liver Function Test Abnormal, Venoocclusive Disease
on Sep 09, 2010 Female patient from UNITED KINGDOM , weighting 136.7 lb, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: dilatation intrahepatic duct acquired, hepatotoxicity, liver function test abnormal, venoocclusive disease. Ketalar dosage: 4 Mg/ml,1-6 Ml/hour Infusion. During the same period patient was treated with NORETHISTERONE (View Norethisterone Review and Norethisterone Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ACICLOVIR (View Aciclovir Review and Aciclovir Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6946626-2 | Cystitis Noninfective
on Aug 16, 2010 Female patient from SPAIN , 23 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis noninfective. Ketalar dosage: Starting 2 Years Prior At First On Weekends, Then Daily For Past 1 1/2 Years, Inhalation.

6920001-9 | Dysuria
Patient was taking Ketalar (View Usage). Patient had the following side effects: dysuria on Aug 02, 2010 from SPAIN Additional patient health information: Female patient , 23 years of age, . Ketalar dosage: .

6749840-4 | Overdose
Adverse event was reported on May 21, 2010 by a Female patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED STATES , 37 years of age, After Ketalar was administered, patient had the following side effects: overdose.

6657258-8 | Blood Pressure Increased
on Dec 09, 2009 Male patient from UNITED STATES , 48 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased. Ketalar dosage: 30 Mg, Intravenous.

6657254-0 | Blood Pressure Increased
on Dec 09, 2009 Female patient from UNITED STATES , 64 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: blood pressure increased. Ketalar dosage: 20 Mg Total, Intravenous.

6657252-7 | Blood Pressure Increased
Patient was taking Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: blood pressure increased on Dec 09, 2009 from UNITED STATES Additional patient health information: Male patient , 27 years of age, . Ketalar dosage: 20 Mg Total, Intravenous.

6607398-4 | Agitation, Apnoea, Blood Creatinine Increased, Blood Glucose Increased, Blood Potassium Increased, Blood Pressure Increased, Grand Mal Convulsion, Hallucination
Adverse event was reported on Feb 15, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: Insufflation) . Location: UNITED KINGDOM , 18 years of age, Patient experienced the following unwanted or unexpected effects: agitation, apnoea, blood creatinine increased, blood glucose increased, blood potassium increased, blood pressure increased, grand mal convulsion, hallucination. During the same period patient was treated with BROMO DRAGONFLY (Oral) (View Bromo-dragonfly Review and Bromo-dragonfly Label ), CANNABIS (CANNABIS SATIVA) (Insufflation) (View Cannabis (cannabis Sativa) Review and Cannabis (cannabis Sativa) Label ), SALBUTAMOL (SALBUTAMOL SULFATE) (View Salbutamol (salbutamol Sulfate) Review and Salbutamol (salbutamol Sulfate) Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ). Patient was hospitalized.

6552090-8 | Cystitis, Metaplasia
on Jan 06, 2010 Female patient from UNITED KINGDOM , 21 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: cystitis, metaplasia. Ketalar dosage: .

6552088-X | Cystitis, Metaplasia
on Jan 06, 2010 Female patient from UNITED KINGDOM , 19 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: cystitis, metaplasia. Ketalar dosage: .

6552079-9 | Cystitis Ulcerative
Patient was taking Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: cystitis ulcerative on Jan 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 24 years of age, . Ketalar dosage: .

6552077-5 | Biopsy Bladder Abnormal, Cystitis Ulcerative
Adverse event was reported on Jan 06, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 32 years of age, Patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative.

6552065-9 | Biopsy Bladder Abnormal, Cystitis Ulcerative
on Jan 06, 2010 Male patient from UNITED KINGDOM , 30 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative. Ketalar dosage: .

6552063-5 | Biopsy Bladder Abnormal, Cystitis Ulcerative
on Jan 06, 2010 Male patient from UNITED KINGDOM , 21 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy bladder abnormal, cystitis ulcerative. Ketalar dosage: .

6552062-3 | Biopsy Bladder Abnormal, Cystitis Ulcerative
Patient was taking Ketalar (View Usage). Patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative on Jan 06, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 28 years of age, . Ketalar dosage: .

6552060-X | Biopsy Bladder Abnormal, Cystitis Ulcerative, Dysplasia
Adverse event was reported on Jan 06, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 30 years of age, After Ketalar was administered, patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative, dysplasia.

6552057-X | Biopsy Bladder Abnormal, Cystitis Ulcerative
on Jan 06, 2010 Female patient from UNITED KINGDOM , 26 years of age, was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy bladder abnormal, cystitis ulcerative. Ketalar dosage: .

6552055-6 | Biopsy Bladder Abnormal, Cystitis
on Jan 06, 2010 Male patient from UNITED KINGDOM , 28 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: biopsy bladder abnormal, cystitis. Ketalar dosage: .

6552054-4 | Biopsy Bladder Abnormal, Cystitis Ulcerative
Patient was taking Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative on Jan 06, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 36 years of age, . Ketalar dosage: .

6552053-2 | Cystitis Ulcerative
Adverse event was reported on Jan 06, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 20 years of age, Patient experienced the following unwanted or unexpected effects: cystitis ulcerative.

6552052-0 | Biopsy Bladder Abnormal, Cystitis Ulcerative
on Jan 06, 2010 Male patient from UNITED KINGDOM , 28 years of age, was treated with Ketalar (View Usage). Patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative. Ketalar dosage: .

6552051-9 | Biopsy Bladder Abnormal, Cystitis Ulcerative
on Jan 06, 2010 Male patient from UNITED KINGDOM , 23 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: biopsy bladder abnormal, cystitis ulcerative. Ketalar dosage: .

6552002-7 | Biopsy Bladder Abnormal, Cystitis Ulcerative
Patient was taking Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy bladder abnormal, cystitis ulcerative on Jan 06, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 28 years of age, . Ketalar dosage: .

6551671-5 | Cystitis Ulcerative
Adverse event was reported on Jan 06, 2010 by a Male patient taking Ketalar (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 21 years of age, Patient had the following side effects: cystitis ulcerative.

6551670-3 | Cystitis
on Jan 06, 2010 Female patient from UNITED KINGDOM , 27 years of age, was treated with Ketalar (View Usage). After Ketalar was administered, patient had the following side effects: cystitis. Ketalar dosage: .

6536923-7 | Bone Marrow Failure, Cystitis
on Dec 23, 2009 Male patient from UNITED KINGDOM , 31 years of age, was diagnosed with bone pain and was treated with Ketalar (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, cystitis. Ketalar dosage: 130 Mg, Qid, Oral; 200 Mg, 5x Per Day, Oral. Patient was hospitalized.

6536906-7 | Cystitis Glandularis, Haematuria, Perineal Pain, Pollakiuria, Pyuria
Patient was taking Ketalar (View Usage). Patient had the following side effects: cystitis glandularis, haematuria, perineal pain, pollakiuria, pyuria on Dec 21, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, . Ketalar dosage: 50 Mg, Qid, Oral, 200 Mg,5x Per Day,oral. During the same period patient was treated with ANALGESICS (View Analgesics Review and Analgesics Label ). Patient was hospitalized.